736 related articles for article (PubMed ID: 27015053)
1. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
Abughosh SM; Wang X; Serna O; Henges C; Masilamani S; Essien EJ; Chung N; Fleming M
J Manag Care Spec Pharm; 2016 Jan; 22(1):63-73. PubMed ID: 27015053
[TBL] [Abstract][Full Text] [Related]
2. A Motivational Interviewing Intervention by Pharmacy Students to Improve Medication Adherence.
Abughosh S; Wang X; Serna O; Esse T; Mann A; Masilamani S; Holstad MM; Essien EJ; Fleming M
J Manag Care Spec Pharm; 2017 May; 23(5):549-560. PubMed ID: 28448784
[TBL] [Abstract][Full Text] [Related]
3. A Motivational Interviewing Intervention to Improve Adherence to ACEIs/ARBs among Nonadherent Older Adults with Comorbid Hypertension and Diabetes.
Mohan A; Majd Z; Johnson ML; Essien EJ; Barner J; Serna O; Gallardo E; Fleming ML; Ordonez N; Holstad MM; Abughosh SM
Drugs Aging; 2023 Apr; 40(4):377-390. PubMed ID: 36847995
[TBL] [Abstract][Full Text] [Related]
4. Accepting Medication Therapy Management Recommendations to Add ACEIs or ARBs in Diabetes Care.
Hurwitz JT; Grizzle AJ; Augustine J; Rehfeld R; Wild A; Abraham I
J Manag Care Spec Pharm; 2016 Jan; 22(1):40-8. PubMed ID: 27015050
[TBL] [Abstract][Full Text] [Related]
5. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior.
Leslie RS; Gilmer T; Natarajan L; Hovell M
J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914
[TBL] [Abstract][Full Text] [Related]
6. Nonadherence to angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs.
Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
J Am Pharm Assoc (2003); 2010; 50(4):527-31. PubMed ID: 20621872
[TBL] [Abstract][Full Text] [Related]
7. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
Majd Z; Mohan A; Paranjpe R; Abughosh SM
J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
[No Abstract] [Full Text] [Related]
8. Patient-Reported Barriers to Adherence Among ACEI/ARB Users from a Motivational Interviewing Telephonic Intervention.
Majd Z; Mohan A; Johnson ML; Essien EJ; Barner JC; Serna O; Gallardo E; Fleming ML; Ordonez N; Holstad MM; Abughosh SM
Patient Prefer Adherence; 2022; 16():2739-2748. PubMed ID: 36217375
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of community pharmacist-provided telephone interventions to improve adherence to hypertension and diabetes medications.
Stanton-Robinson C; Al-Jumaili AA; Jackson A; Catney C; Veach S; Witry MJ
J Am Pharm Assoc (2003); 2018; 58(4S):S120-S124. PubMed ID: 29891173
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Medication Management and Medication Adherence for Chronic Conditions.
Brummel A; Carlson AM
J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052
[TBL] [Abstract][Full Text] [Related]
11. Trajectories of adherence to ACEI/ARB medications following a motivational interviewing intervention among Medicare Advantage beneficiaries in Texas.
Majd Z; Mohan A; Fatima B; Johnson ML; Essien EJ; Abughosh SM
Patient Educ Couns; 2024 Feb; 119():108073. PubMed ID: 38039785
[TBL] [Abstract][Full Text] [Related]
12. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence.
Abughosh SM; Vadhariya A; Johnson ML; Essien EJ; Esse TW; Serna O; Gallardo E; Boklage SH; Choi J; Holstad MM; Fleming ML
J Manag Care Spec Pharm; 2019 Oct; 25(10):1053-1062. PubMed ID: 31556824
[TBL] [Abstract][Full Text] [Related]
13. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
Yokoyama K; Yang W; Preblick R; Frech-Tamas F
J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
[TBL] [Abstract][Full Text] [Related]
14. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study.
Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB
Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889
[TBL] [Abstract][Full Text] [Related]
15. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
Mayyas F; Bataineh W; Jarab A
Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
Leslie RS; Tirado B; Patel BV; Rein PJ
J Manag Care Spec Pharm; 2014 Dec; 20(12):1193-203. PubMed ID: 25443513
[TBL] [Abstract][Full Text] [Related]
17. Comparing adherence and persistence across 6 chronic medication classes.
Yeaw J; Benner JS; Walt JG; Sian S; Smith DB
J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264
[TBL] [Abstract][Full Text] [Related]
18. Impact of Community Pharmacist Interventions With Managed Care to Improve Medication Adherence.
Daly CJ; Verrall K; Jacobs DM
J Pharm Pract; 2021 Oct; 34(5):694-702. PubMed ID: 31884874
[TBL] [Abstract][Full Text] [Related]
19. Medication Nonadherence Among Medicare Beneficiaries with Comorbid Chronic Conditions: Influence of Pharmacy Dispensing Channel.
Iyengar RN; LeFrancois AL; Henderson RR; Rabbitt RM
J Manag Care Spec Pharm; 2016 May; 22(5):550-60. PubMed ID: 27123916
[TBL] [Abstract][Full Text] [Related]
20. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
